V

    Veeva Systems Inc Class A (VEEV)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $285.68
    +8.99 (+3.25%)

    Market Cap: $44.80B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    100%(40/40)
    Avg Surprise
    +11.04%
    Streak
    52 Q

    Upcoming Estimates

    Oct 31, 2026
    EPS Consensus$2.28
    Range$2.24 - $2.37
    26 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$2.25-1.3%
    60d ago$2.29+0.1%
    30d ago$2.29+0.1%
    7d ago$2.28+0.0%
    Current$2.28
    Revenue Consensus
    $918M
    Range$911M - $937M
    24 analysts
    Jan 31, 2027
    EPS Consensus$2.42
    Range$2.36 - $2.57
    27 analysts
    Revenue Consensus
    $965M
    Range$956M - $1.0B
    27 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jan 27EST
    -$2.42---
    Oct 26EST
    -$2.28---
    Jul 26
    $1.68$1.62+3.70%Beat-15.6%
    Apr 26
    $2.24$2.14+4.67%Beat+13.7%
    Jan 26
    $2.06$1.94+6.19%Beat+18.4%
    Oct 25
    $2.04$1.95+4.62%Beat+16.6%
    Jul 25
    $1.99$1.90+4.74%Beat+22.8%
    Apr 25
    $1.97$1.74+13.22%Beat+31.3%
    Jan 25
    $1.74$1.58+10.13%Beat+26.1%
    Oct 24
    $1.75$1.58+10.76%Beat+30.6%
    Jul 24
    $1.62$1.53+5.88%Beat+33.9%
    Apr 24
    $1.50$1.42+5.63%Beat+64.8%
    Jan 24
    $1.38$1.30+6.15%Beat+20.0%
    Oct 23
    $1.34$1.29+3.88%Beat+18.6%
    Jul 23
    $1.21$1.13+7.08%Beat+17.5%
    Apr 23
    $0.91$0.80+13.75%Beat-8.1%
    Jan 23
    $1.15$1.04+10.58%Beat+27.8%
    Oct 22
    $1.13$1.07+5.61%Beat+16.5%
    Jul 22
    $1.03$1.01+1.98%Beat+9.6%
    Apr 22
    $0.99$0.92+7.61%Beat+8.8%
    Jan 22
    $0.90$0.88+2.27%Beat+15.4%
    Oct 21
    $0.97$0.88+10.23%Beat+24.4%
    Jul 21
    $0.94$0.86+9.30%Beat+30.6%
    Apr 21
    $0.91$0.78+16.67%Beat+37.9%
    Jan 21
    $0.78$0.68+14.71%Beat+44.4%
    Oct 20
    $0.78$0.68+14.71%Beat+30.0%
    Jul 20
    $0.72$0.64+12.50%Beat+30.9%
    Apr 20
    $0.66$0.59+11.86%Beat+32.0%
    Jan 20
    $0.54$0.52+3.85%Beat+20.0%
    Oct 19
    $0.60$0.54+11.11%Beat+33.3%
    Jul 19
    $0.55$0.49+12.24%Beat+41.0%
    Apr 19
    $0.50$0.45+11.11%Beat+51.5%
    Jan 19
    $0.45$0.40+12.50%Beat+95.7%
    Oct 18
    $0.45$0.38+18.42%Beat+80.0%
    Jul 18
    $0.39$0.34+14.71%Beat+69.6%
    Apr 18
    $0.33$0.31+6.45%Beat+50.0%
    Jan 18
    $0.23$0.21+9.52%Beat+4.5%
    Oct 17
    $0.25$0.21+19.05%Beat+13.6%
    Jul 17
    $0.23$0.20+15.00%Beat-
    Apr 17
    $0.22$0.18+22.22%Beat-
    Jan 17
    $0.22$0.17+29.41%Beat-
    Oct 16
    $0.22$0.16+37.50%Beat-

    Key Metrics

    Valuation
    P/E Ratio35.62EV/EBITDA36.02x
    Price/FCF28.30xFCF Yield3.53%
    Profitability
    Profit Margin29.30%Operating Margin29.60%
    ROE14.40%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio5.46xQuick Ratio5.46x
    Trading Statistics
    Beta0.92Avg Volume2.09M
    52-Week High$310.5052-Week Low$148.05

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$257.68
    SMA 20$244.90
    SMA 50$210.26
    SMA 200$198.82
    EMA 10$260.87
    EMA 20$246.14
    EMA 50$219.66
    EMA 200$206.97

    MACD

    Line: 18.43Signal: 15.81Hist: 2.62

    ADX

    ADX: 49.4+DI: 47.6-DI: 8.3

    Aroon & PSAR

    Aroon Up92.0
    Aroon DownN/A
    PSAR$241.20

    Bollinger Bands

    Upper Band$284.55
    Lower Band$205.25
    %B Position3238%(Upper)
    Band Width1.01

    RSI (14-Day)

    Overbought
    77.3

    Momentum Oscillators

    Stoch %K77.9
    Stoch %D76.8
    Williams %R-16.0
    ROC (10d)19.9%
    Momentum47.34
    CCI (20d)186.6
    MFI (14d)61.5

    Volatility Measures

    ATR (14d)$11.37(4.0%)
    StdDev (20d)19.82
    Hist Vol62.7%(High)

    Volume Flow

    VWAP$283.64
    OBV-13.7M
    AD Line-26.4M
    CMF (20d)0.192

    Volume Metrics

    Avg Vol (20d)2.1M
    Vol Ratio1.4x
    VWMA (20d)$251.59

    Pivot Points

    R3$290.33
    R2$287.50
    R1$282.10
    Pivot Point$279.27
    S1$273.87
    S2$271.04
    S3$265.64

    Advanced Oscillators

    TSI47.27
    Ultimate Osc65.2
    KST279.66

    Financial Data

    QuarterJul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024Jan 2024Oct 2023
    Total Revenue$927.96M$882.95M$835.95M$811.24M$789.08M$759.04M$720.89M$699.21M$676.18M$650.35M$630.62M$616.50M
    Cost of Revenue$232.01M$220.92M$213.48M$199.47M$195.25M$173.82M$180.99M$174.39M$170.37M$173.88M$173.93M$167.68M
    Gross Profit$695.95M$662.02M$622.47M$611.77M$593.83M$585.22M$539.89M$524.82M$505.81M$476.46M$456.69M$448.82M
    Operating Expenses$420.93M$388.91M$376.60M$370.92M$397.92M$351.49M$351.47M$343.46M$339.32M$321.29M$321.42M$320.33M
    R&D$222.92M$208.32M$198.79M$191.88M$192.68M$184.03M$181.53M$172.41M$176.43M$162.71M$163.56M$161.28M
    SG&A$71.31M$69.47M$67.63M$68.48M$95.80M$68.83M$70.74M$72.36M$61.37M$61.28M$58.66M$62.28M
    Operating Income$275.02M$273.11M$245.88M$240.85M$195.91M$233.73M$188.42M$181.35M$166.49M$155.17M$135.27M$128.49M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$349.53M$347.53M$317.54M$312.79M$265.36M$298.82M$245.13M$242.29M$225.06M$206.90M$182.69M$170.68M
    Income Tax Expense$76.10M$86.59M$73.33M$76.58M$65.06M$70.63M$49.51M$56.48M$54.02M$45.24M$35.30M$35.52M
    Net Income$273.43M$260.94M$244.20M$236.20M$200.31M$228.19M$195.63M$185.81M$171.04M$161.66M$147.40M$135.16M
    EBITDA$364.25M$362.23M$322.77M$312.21M$277.63M$310.18M$255.08M$257.54M$224.21M$213.02M$189.44M$174.07M
    EBIT$349.53M$347.53M$317.54M$312.79M$265.36M$298.82M$245.13M$242.29M$225.06M$206.90M$182.69M$170.68M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    Veeva (VEEV): A Record-Keeper Whose Own Books Are Under Audit

    Veeva is the regulated life-sciences system of record, owning narrow workflows with high switching costs, layering AI agents across core apps, and focusing on industry penetration not broad enterprise competition Fiscal Q1 revenue $882.9M up 16% YoY, subscription revenue $730.2M up 15%, non-GAAP EPS $2.24, GAAP net income $260.9M up 14%, management raised FY27 revenue to $3.635-3.645B and EPS to about $9.05 Operating quality and balance sheet strength are high - gross margin 75.0%, operating margin 30.9%, net margin 28.4%, net cash ~$1.88B, current ratio 4.74, Altman Z >11, Beneish M-score -2.62, Market repricing created an opening - stock down ~45% TTM and ~48% below 52-week high $310.50, trading at 17.7x forward EPS and 0.72 PEG, Wall Street target $245.48 Skepticism centers on stock-based compensation - Q1 SBC $119.3M annualized ~$477M, Veeva remains GAAP profitable and survives the compensation-adjusted cash flow test better than many peers

    Unknown Author
    6/17/26
    170
    Life Sciences Software
    Quality Compounder
    Also mentions:
    CRM
    ADBE

    News

    Frequently Asked Questions About VEEV

    Does VEEV pay dividends?
    Veeva Systems Inc Class A (VEEV) does not currently pay a regular dividend.
    What is VEEV's P/E ratio?
    Veeva Systems Inc Class A has a price-to-earnings (P/E) ratio of 35.62.
    What is VEEV's market cap?
    Veeva Systems Inc Class A (VEEV) has a market capitalization of $44.80B with a current stock price of $285.68.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.